Cilostazol and Primary-PCI: Mirage or Good Alternative?

E-ISSN： 1875-6212|10|4|468-471

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.10, Iss.4, 2012-07, pp. : 468-471

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azathioprine as an alternative treatment in primary hypophysitis

By Papanastasiou L.

Pituitary, Vol. 14, Iss. 1, 2011-03 ,pp. : 16-22

Springer Publishing Company

Access to resources Recommend Favorite

Impact of primary PCI volume on hospital mortality in STEMI patients: does time-to-presentation matter?

By Navarese Eliano

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 2, 2011-08 ,pp. : 223-231

Springer Publishing Company

Access to resources Recommend Favorite

Primary PCI for ST elevation AMI save lives and money – what more do we want?

By Clemmensen Peter Jurlander Birgit

Scandinavian Cardiovascular Journal, Vol. 39, Iss. 5, 2005-10 ,pp. : 264-266

Informa Healthcare

Access to resources Recommend Favorite

Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects

By Duntas Leonidas

Endocrine, Vol. 39, Iss. 3, 2011-06 ,pp. : 199-204

Springer Publishing Company

Access to resources Recommend Favorite

Health-related quality of life one month after thrombolysis or primary PCI in patients with ST-elevation infarction. A DANAMI-2 sub-study.

By Mortensen O. S. Bjorner J. B. Oldenburg B. Newman B. Groenvold M. Madsen J. K. Andersen H. R.

Scandinavian Cardiovascular Journal, Vol. 39, Iss. 4, 2005-09 ,pp. : 206-212

Informa Healthcare

Access to resources Recommend Favorite